tradingkey.logo

Aditxt more than doubles after Appili takeover deadline extended

ReutersMar 18, 2025 3:07 PM

Shares of biotech firm Aditxt Inc ADTX.O rise 122% to $9.68

ADTX's acquisition of Canada-based drug developer Appili Therapeutics APLI.TO has been given extended deadline of March 31, after APLI granted waiver

APLI secured court approvals for transaction and its shareholders have voted in favor of deal

However, deal remains subject to ADTX securing sufficient financing

APLI to be delisted from Toronto Stock Exchange after acquisition, expected in Q1 2025

More than 51.9 million ADTX shares traded, 73x their 25-day moving average

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI